aTyr Pharma, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|
| Assets | ||||
| Cash & Equivalents | $21.1M | $38.4M | $53.0M | $13.9M |
| Accounts Receivable | — | — | — | — |
| Inventory | — | — | — | — |
| Total Current Assets | $87.0M | $74.8M | $98.0M | $16.5M |
| Property, Plant & Equipment | $2.3M | $1.4M | $1.8M | $1.9M |
| Goodwill | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — |
| Total Assets | $89.4M | $80.5M | $129.7M | $20.6M |
| Liabilities | ||||
| Accounts Payable | $2.3M | $2.6M | $3.9M | $1.4M |
| Total Current Liabilities | $10.4M | $8.5M | $12.1M | $10.1M |
| Long-Term Debt | $14.7M | $9.2M | $1.8M | — |
| Total Liabilities | $25.1M | $17.7M | $14.6M | $111.7M |
| Stockholders' Equity | ||||
| Retained Earnings | $-264.2M | $-216.0M | $-158.1M | $-110.2M |
| Total Stockholders' Equity | $64.2M | $62.8M | $115.1M | $-91.0M |